Guex, J.-J., Allaert, F.-A., Gillet, J.-L. and Chleir, F. (2005) Immediate and Midterm Complications of Sclerotherapy. Report of a Prospective Multicenter Registry of 12173 Sclerotherapy Sessions. Dermatologic Surgery, 31, 123-128.
https://doi.org/10.1097/00042728-200502000-00001

has been cited by the following article:

• TITLE: Novel Developments in Polidocanol Sclerotherapy: A Review

  AUTHORS: Xiang Zheng, Qiming Wei, Hong Zhang

  KEYWORDS: Polidocanol, Sclerosant, Sclerotherapy, Foam

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.6 No.8, August 6, 2018

  ABSTRACT: Polidocanol is the most widely used Sclerotherapy in European and American countries. It is affordable, easy to use and apply, and has high efficiency. The purpose of this paper is to give an overview of the recent basics of the Sclerotherapy, chemistry and formulation, clinical applications, and side-effects and complications of Polidocanol, and to discuss the Polidocanol as the safety and efficacy of Sclerotherapy.